What's new

Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation: 02/12/2008, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation: 02/12/2008, Revision: 21, Status: Authorised

Apr 22, 2025 - 16:07
 0
Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation: 02/12/2008, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation: 02/12/2008, Revision: 21, Status: Authorised
Read More

Tags:

Previous Article

'Severe consequences of government overreach': Harvard sues Trump admin over fun...

Next Article

Mandate, objectives and rules of procedure of the Scientific Advice Working Part...

Related Posts

Biologics Working Party Vaccines Quality Operational Ex...

Apr 1, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): RoActemra, tocilizumab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Infections and infestations, PIP number: P/0028/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 12, 2025  0

Regulation (EU) 2024/568: Questions and answers clinic for the Veterinary Industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 February 2025, 15:00 (CET) to 11 February 2025, 16:00 (CET)

Regulation (EU) 2024/568: Questions and answers clinic ...

Feb 13, 2025  0